Home
Flexion Therapeutics

Flexion Therapeutics Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainflexiontherapeutics.com

Year Founded2007

Employees201 - 500

Annual Revenue$100M - $200M

Flexion Therapeutics

Flexion Therapeutics (including company regionals)

flexiontherapeutics.com

See more website traffic and engagement information

Flexion Therapeutics Revenue up to June 2026 is 100M - 200M

revenue generated by Flexion Therapeutics top domains

Flexion Therapeutics top domains revenue over 3 years

Revenue for Flexion Therapeutics top domains

flexiontherapeutics.com100M - 200M

See more with Sales Intelligence

Total visits to Flexion Therapeutics's top domains

Understand Flexion Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Flexion Therapeutics's top domains

Analyze Flexion Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Flexion Therapeutics's top domains

See how Flexion Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Flexion Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

concertpharma.comCompany NameConcert PharmaceuticalsEmployees51 - 200HQUnited States, Massachusetts, LexingtonAnnual revenue< $1MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Flexion Therapeutics

These are the website technologies, by industry, used by Flexion Therapeutics top domains

Widget (6)

Twemoji

Advertising (5)

DoubleClick

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

More Technologies

9

See all

News & Signals from Flexion Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFlexion Therapeutics launched Zilretta on Nov 1st '17.Additionally, in November 2017, Flexion Therapeutics Inc. launched Zilretta, an intra-articular injection for OA-related knee pain.

NewsFlexion Therapeutics has issues with potential violations of the federal securities laws and/or breaches of fiduciary duties.Flexion Therapeutics, Inc. (NASDAQ: FLXN ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Pacira BioSciences, Inc. for $8.50 per share in cash plus one non-tradeable contingent value right worth up to $8.00 per share in cash.

NewsPaxira acquires Flexion Therapeutics.Paxira’s acquisition of Flexion gives them access to the latter’s lead product, Zilretta (triamcinolone acetonide extended-release injectable suspension), a non-opioid injection intended for pain relief.